查詢結果分析
來源資料
相關文獻
- Comparison of Clinical Behaviors and Responses to Radiation between Squamous Cell Carcinomas and Adenocarcinomas/Adenosquamous Carcinomas of the Cervix
- Survival Advantages and Complications of Adjuvant Therapy in Early-Stage Cervical Cancer with Pelvic Node Metastasis
- Clinincal Characteristics and Management of Enterovesical Fistulas
- Well-Differentiated Papillary Villoglandular Adenocarcinoma of the Uterine Cervix: A Case Report
- 以皮膚穴道電機能篩檢儀對婦科腫瘤病人治療前後及恢復期之觀察
- Implications of a Failed Prospective Trial of Adjuvant Therapy after Radical Hysterectomy for Stage Ib-IIa Cervical Carcinoma with Pelvic Node Metastases
- 推展婦女子宮頸癌防治工作策略與成果
- 子宮頸癌的化學治療
- SCC抗原於子宮頸癌臨床診治上的價值
- 靈芝水溶液對婦癌細胞生長之抑制效果
頁籤選單縮合
題 名 | Comparison of Clinical Behaviors and Responses to Radiation between Squamous Cell Carcinomas and Adenocarcinomas/Adenosquamous Carcinomas of the Cervix=比較子宮頸腺癌/腺鱗狀上皮癌與鱗狀上皮癌之臨床行為及放射反應 |
---|---|
作 者 | 洪志宏; 蔡介生; 王俊傑; 賴瓊慧; 陳文政; 李百勛; 張廷彰; 曾志仁; | 書刊名 | 長庚醫學 |
卷 期 | 23:7 2000.07[民89.07] |
頁 次 | 頁396-404 |
分類號 | 417.2832 |
關鍵詞 | 子宮頸癌; 腺癌/腺鱗狀上皮癌; 臨床行為; 放射反應; Cervical cancer; Adenocarcinomas and adenosquamous carcinomas; Clinical behaviors; Radiation responses; |
語 文 | 英文(English) |
英文摘要 | Background. Adenocarcinomas/adenosquamous carcinomas (AC/ASC) are relatively uncommon histological subtypes in cervical cancer. In this study, we retrospectively compared the clinical behaviors and responses to radiation of squamous cell carcinomas (SCC) and AC/ASC in patients with stage I-IVA cervical cancer primarily treated by radiotherapy (RT). Methods. Nine hundred twenty-eight patients with cervical cancer primarily treated with RT were included in this study. Ninety-four percent of the patients had SCC and 6% had AC/ASC. The association of histological subtype to various clinical parameters was assessed. Tumor response and failure patterns were analyzed, and the prognostic significance of histological subtype and other clinical parameters were evaluated by univariate and multivariate analyses. Results. (1) Patients with AC/ASC had a significantly higher percentage of bulky I- IIA disease, a younger age (< 45 years), and an elevated carcinoembryonic antigen (CEA) level, but a lower percentage of elevated squamous cell carcinoma antigen (SCC-Ag) level, than patients with SCC. Hemoglobin (Hb) levels and lymph node status were not significantly different between SCC and AC/ASC patients. (2) A higher percentage of AS/ASC patients had residual induration 2 to 3 months after RT than those with SCC (40% vs. 21.6%, p=0.008). Higher local failure rates were found for AC/ASC patients compared to SCC patients (38% vs. 15%, p=0.001). (3) The 5- year disease-specific survival rate was 66% and 50% for SCC and AC/ASC patients, respectively (p=0.016). Advanced stages, Hb levels lower than 10 g/dl, positive lymph nodes, AC/ASC histological subtype, and SCC-Ag levels higher than 10 ng/ml were independent prognostic factors for worse survival for all patients. For patients with AC/ASC in particular, only stage and positive lymph nodes were significant prognostic factors. Conclusion. Cervical cancer patients with AC/ASC are relatively younger and have a higher incidence of elevated CEA and a lower incidence of elevated SCC-Ag levels than those with SCC. For AC/ASC patients, the tumor responses to RT were relatively slow and poor. This group of patients had a worse survival rate than patients with SCC, mainly because of the higher incidence of uncontrolled local disease for AC/ASC patients. |
本系統中英文摘要資訊取自各篇刊載內容。